<PAGE>
EXHIBIT 4.2
FIFTH AMENDED AND RESTATED
INVESTOR RIGHTS AGREEMENT
FIFTH
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this
"Agreement")
made as of September 21, 2005 (the "Effective Date") by and among
(i) PTC
Therapeutics, Inc., a Delaware corporation (the "Company"), (ii)
the persons
identified on the signature page of this Agreement as Founders (the
"Founders"),
(iii) those Holders of shares of Series A Stock and Series B Stock
(each as
defined below) of the Company listed on Exhibit A attached hereto
(the "Series A
and Series B Investors"), (iv) those Holders of shares of Series C
Stock (as
defined below) of the Company listed on Exhibit B attached hereto
(the "Series C
Purchasers"), (v) the Holders of shares of Series D Stock (as
defined below) of
the Company listed on Exhibit C attached hereto (the "Series D
Purchasers"),
(vi) those Holders of Series E Stock (as defined below) of the
Company listed on
Exhibit D attached hereto (the "Series E Purchasers"), (vii) the
purchasers of
Series E-2 Stock (as defined below) of the Company listed on
Exhibit E attached
hereto (the "Series E-2 Purchasers") and (viii) the holders of
warrants to
purchase Preferred Stock and/or Common Stock of the Company listed
on Exhibit F
attached hereto (the "Warrant Purchasers"). The Series A and Series
B Investors,
the Series C Purchasers, the Series D Purchasers, the Series E
Purchasers and
the Series E-2 Purchasers may be referred to herein individually as
an
"Investor" and collectively as the "Investors." The Founders and
the Investors
may be referred to herein individually as a "Stockholder" and
collectively as
the "Stockholders."
WHEREAS,
the Company proposes to issue and sell up to an aggregate of
4,132,232 shares of Series E-2 Convertible Preferred Stock, par
value $.001 per
share (the "Series E-2 Stock"), to the Series E-2 Purchasers
pursuant to that
certain Subscription Agreement dated as of the date hereof among
the Company and
the Series E-2 Purchasers (the "Subscription Agreement");
WHEREAS,
in connection with their respective purchases of shares of the
Series C Stock, the Series D Stock, the Series E Stock and the
Series E-2 Stock,
the Series C Purchasers, the Series D Purchasers, the Series E
Purchasers and
the Series E-2 Purchasers have requested that the Company extend to
them
registration rights and certain other rights and covenants as set
forth herein,
and the Series C Purchasers, the Series D Purchasers, the Series E
Purchasers
and the Series E-2 Purchasers have requested that the Founders
enter into
certain restrictions on the transfer of Common Stock (as
hereinafter defined)
owned or controlled by such Founders;
WHEREAS,
in connection with their purchase of certain warrants, the
Warrant Purchasers have requested that the Company extend to them
registration
rights as set forth herein;
WHEREAS,
the Board of Directors of the Company has determined that it is
in the best interests of the Company that the Company enter into
this Agreement;
and
WHEREAS,
the Company and the holders of two-thirds of the outstanding
shares of the Company's Series A Convertible Preferred Stock, par
value $.001
per share (the
<PAGE>
"Series A Stock"), the Company's Series B Convertible Preferred
Stock, par value
$.001 per share (the "Series B Stock"), the Company's Series C
Convertible
Preferred Stock, par value $.001 per share (the "Series C Stock"),
the holders
of the Company's Series D Convertible Preferred Stock, par value
$.001 per share
(the "Series D Stock") and the Company's Series E Convertible
Preferred Stock,
par value $.001 per share (the "Series E Stock") (the Series A
Stock, the Series
B Stock, the Series C Stock, the Series D Stock, the Series E Stock
and the
Series E-2 Stock, collectively being referred to herein as the
"Preferred
Stock") have consented to the terms of this Agreement and the
amendment and
restatement of that certain Fourth Amended and Restated Investor
Rights
Agreement, dated as of December 17, 2003, among the Company and the
Investors
named therein (the "Fourth Amended Rights Agreement"), which
amended and
restated that certain Third Amended and Restated Investor Rights
Agreement,
dated as of August 17, 2001, among the Company and the Investors
named therein
(the "Third Amended Rights Agreement"), which amended and restated
that certain
Second Amended and Restated Investor Rights Agreement dated as of
May 26, 2000
among the Company and the Investors named therein (the "Second
Amended Rights
Agreement") which amended and restated that certain Amended and
Restated
Investor Rights Agreement dated as of February 9, 2000 among the
Company and the
Investors named therein (the "Amended Rights Agreement"), which
amended and
restated that certain Investor Rights Agreement dated as of August
19, 1998
among the Company and the Series A and Series B Investors named
therein (the
"Original Rights Agreement"), as set forth herein and have
evidenced such
consent by executing and delivering either (i) an omnibus signature
page in the
form attached hereto as Exhibit H-1 or (ii) a written consent of
stockholders in
the form attached hereto as Exhibit H-2 to this Agreement.
NOW,
THEREFORE, in consideration of the covenants and agreements set
forth
herein and for other good and valuable consideration, the receipt
and
sufficiency of which are hereby mutually acknowledged, the parties
hereto amend
and restate in its entirety the Third Amended Rights Agreement and
covenant and
agree as follows:
1. GENERAL
PROVISIONS
1.1. SHARES SUBJECT TO THIS AGREEMENT. The Stockholders expressly
agree that the
terms and restrictions of this Agreement shall apply to all shares
of capital
stock which any of them now owns or hereafter acquires by any
means, including
without limitation by purchase, assignment or operation of law, or
as a result
of any stock dividend, stock split, reorganization,
reclassification, whether
voluntary or involuntary, or other similar transaction, and to any
shares of
capital stock of any successor in interest of the Company, whether
by sale,
merger, consolidation or other similar transaction, or by purchase,
assignment
or operation of law (the "Shares").
1.2. NO PARTNERSHIP RELATIONSHIP. Notwithstanding, but not in
limitation of, any
other provision of this Agreement, the parties understand and agree
that the
creation, management and operation of the Company shall not create
or imply a
general partnership between or among the Stockholders and shall not
make any
Stockholder the agent or partner of any other Stockholder for any
purpose.
2
<PAGE>
1.3. CERTAIN DEFINITIONS. As used in this Agreement, the following
terms shall
have the following respective meanings:
"Additional Closing Date" shall have the meaning assigned to such
term in
the Subscription Agreement.
"Affiliate" has the meaning ascribed to that term in Rule 12b-2
under the
Exchange Act, or any successor rule.
"Commission" shall mean the Securities and Exchange Commission and
any
successor agency of the Federal government administering the
Securities Act and
the Exchange Act.
"Common
Stock" shall mean (i) the common stock, $.001 par value per
share,
of the Company, (ii) any other capital stock of the Company,
however designated,
authorized on or after the date hereof, which shall neither be
limited to a
fixed sum or percentage of par value in respect of the rights of
the holders
thereof to participate in dividends nor entitled to a preference in
the
distribution of assets upon the voluntary or involuntary
liquidation,
dissolution or winding up of the Company; and (iii) any other
securities into
which or for which any of the securities described in (i) or (ii)
may be
converted or exchanged pursuant to a plan of recapitalization,
reorganization,
merger, consolidation, sale of assets or other similar
transaction.
"Company
Stock Option Plan" shall mean the Company's 1998 Employee,
Director and Consultant Stock Option Plan (as amended from
time-to-time); or
such other arrangements, contracts, or plans as are recommended by
management
and approved by the Board of Directors or compensation committee
established by
the Board of Directors.
"Exchange
Act" shall mean the Securities Exchange Act of 1934, as
amended,
and any similar or successor Federal statute, and the rules and
regulations of
the Commission thereunder, all as the same shall be in effect from
time to time.
"Holder"
shall mean the Investors and Warrant Purchasers holding
Registrable Securities or securities convertible into Registrable
Securities and
any person holding such securities to whom the rights under this
Agreement have
been transferred in accordance with Section 4.12 hereof.
"Initial
Closing Date" shall have the meaning assigned to such term in
the
Subscription Agreement.
"Initial
Public Offering" shall mean either (i) the first underwritten
public offering of Common Stock of the Company, offered on a firm
commitment
basis pursuant to a registration statement filed with the
Commission under the
Securities Act on Form S-1 or its then equivalent with net proceeds
to the
Company of not less than $50,000,000 and a per share price of not
less than an
amount equal to two times the Adjusted Series E-2 Price (subject to
equitable
adjustment in the event of any stock dividend, stock split,
combination,
reorganization, recapitalization or similar event involving a
change in the
Common Stock) or (ii) any other public offering upon the written
election of the
3
<PAGE>
Company and Holders of at least sixty-six and two-thirds percent
(66 2/3 %) of
the outstanding shares of Preferred Stock, on an as-converted
basis.
"Person"
means an individual, corporation, company, partnership, joint
venture, trust or unincorporated organization, or a government or
any agency or
political subdivision thereof.
The terms
"register", "registered" and "registration" shall refer to a
registration effected by preparing and filing a registration
statement in
compliance with the Securities Act and applicable rules and
regulations
thereunder, and the declaration or ordering of the effectiveness of
such
registration statement, or, as the context may require, under the
Exchange Act
or applicable state securities laws.
"Registrable Securities" shall mean any (i) shares of Common Stock
issued
or issuable pursuant to the conversion of the Preferred Stock; (ii)
shares of
Common Stock issued or issuable pursuant to the exercise of the
Warrants (and
the conversion of any Preferred Stock issued or issuable pursuant
thereto)
pursuant to the terms set forth therein and (iii) shares of Common
Stock issued
or issuable pursuant to the conversion of the Preferred Stock, the
exercise of
the Warrants or the exercise or conversion of any warrant, right or
other
security issued in exchange for or in replacement of the Preferred
Stock or
issued with respect to the Preferred Stock or issued upon any stock
split, stock
dividend or other distribution, recapitalization, reorganization,
merger,
consolidation, sale of assets or similar event. As to any
particular Registrable
Securities, once issued, such securities shall cease to be
Registrable
Securities when (a) a registration statement with respect to the
sale of such
securities shall have become effective under the Securities Act and
such
securities shall have been disposed of in accordance with such
registration
statement, (b) they shall have been sold as permitted by Rule 144
(or any
successor provision) under the Securities Act and the purchaser
thereof does not
receive "restricted securities" as defined in Rule 144, (c) they
shall have been
otherwise transferred, new certificates for them not bearing a
legend
restricting further transfer shall have been delivered by the
Company and
subsequent public distribution of them shall not, in the opinion of
counsel for
the holders, require registration of them under the Securities Act
or (d) they
shall have ceased to be outstanding.
"Registration Expenses" shall mean the expenses so described in
Section
4.7.
"Securities Act" shall mean the Securities Act of 1933, as amended,
and
any similar or successor Federal statute, and the rules and
regulations of the
Commission thereunder, all as the same shall be in effect from time
to time.
"Selling
Expenses" shall mean the expenses so described in Section 4.7.
"Subsidiary" or "Subsidiaries" shall mean any corporation,
partnership,
trust or other entity of which the Company and/or any of its other
Subsidiaries
directly or indirectly owns at the time a majority of the
outstanding shares of
any class of equity security of such corporation, partnership,
trust or other
entity.
4
<PAGE>
"Warrants"
shall mean those certain warrants to purchase capital stock
issued by the Company to the Warrant Purchasers listed on Exhibit E
attached
hereto.
2.
PERCENTAGE MAINTENANCE RIGHTS
2.1. NOTICE OF NEW ISSUANCE. Except with respect to "Exempt
Issuances" as
defined in Section 2.3, in the event that the Company issues any
(i) shares of
Common Stock, (ii) warrants, options or other rights to purchase
Common Stock
(collectively, "Rights"), or (iii) any debentures or other
securities
convertible into or exchangeable for shares of Common Stock
(collectively,
"Convertible Securities"), the Company will deliver to those
Investors then
holding more than half of one percent (0.5%) of the shares of the
Preferred
Stock (each a "Qualified Stockholder") a notice (the "Offer
Notice") upon the
completion of such issuance (the "New Issuance"), stating the price
and other
terms and conditions thereof.
2.2. RIGHT TO PURCHASE SHARES, RIGHTS OR CONVERTIBLE SECURITIES. In
the event of
a New Issuance (other than an Exempt Issuance), any Qualified
Stockholder shall
have the right to purchase such number of shares of Common Stock,
Rights or
Convertible Securities at the price and on the terms upon which the
New Issuance
was made, such price to be paid in full in cash or by check at the
time of
issuance of such securities to such Qualified Stockholders so that,
after giving
effect to the issuance to the Qualified Stockholders and the
conversion,
exercise and exchange into or for (whether directly or indirectly)
shares of
Common Stock of all such Rights and Convertible Securities, each
Qualified
Stockholder who exercises such right will continue to maintain its
same
proportionate ownership of Common Stock as of the date immediately
preceding the
New Issuance, treating each Qualified Stockholder, for the purpose
of such
computation, as the Holder of the number of shares of Common Stock
which would
be issuable to it upon conversion, exercise and exchange of all
Rights and
Convertible Securities held by it on the date immediately preceding
the New
Issuance and assuming the like conversion, exercise and exchange of
all such
securities held by other persons. The rights set forth in this
Article 2 shall
be exercised by the Qualified Stockholders, if at all, by written
notice to the
Company delivered not later than thirty (30) days after the receipt
by the
Investors of the Offer Notice in accordance with the terms and
conditions stated
therein, and such right shall expire with respect to a Qualified
Stockholder at
the end of the thirtieth day after the day of the receipt by such
Qualified
Stockholders of the Offer Notice. The Company shall, promptly
following the
expiration of such thirty (30) day period, notify all Qualified
Stockholders who
have exercised their purchase rights under this Section 2.2 of the
aggregate
number of shares of Common Stock, Rights and Convertible Securities
to be issued
pursuant to this Section 2.2, and afford each Qualified Stockholder
the
opportunity to adjust the number of such securities it purchases
under this
Section 2.2 in order to conform its proportionate ownership after
the New
Issuance and the exercise of rights under this Section 2.2 to its
proportionate
ownership as of the date immediately preceding the New
Issuance.
2.3. EXEMPT ISSUANCES. The issuances referred to in Section 2.1
which will not
give the Investors the rights described in Section 2.2 (the "Exempt
Issuances")
are issuances in which shares of Common Stock or Rights or
Convertible
Securities of the Company are
5
<PAGE>
issued or deemed issued (i) as a dividend or distribution payable
pro rata to
all holders of Common Stock or other securities of the Company;
(ii) up to
2,326,008 shares of Common Stock (subject to equitable adjustment
in the event
of any stock dividend, stock split, combination,
reorganization,
recapitalization or similar event involving a change in the Common
Stock),
including Options therefor, pursuant to the Corporation's 1998
Employee Director
and Consultant Stock Option Plan (as amended from time-to-time);
and shares of
Common Stock or Options therefor in excess of such 2,326,008 shares
that are
issued pursuant to the Corporation's 1998 Employee, Director and
Consultant
Stock Option Plan (as amended from time-to-time), or such other
arrangements,
contracts, or plans that are recommended by management and approved
by the Board
of Directors or compensation committee established by the Board of
Directors,
upon written consent of the holders of a majority of the Preferred
Stock; (iii)
upon conversion or exercise of any Rights (including shares issued
in connection
with any subsequent conversion of the shares issued upon the
exercise of such
Rights) or Convertible Securities outstanding on the date hereof;
(iv) as up to
4,132,232 shares of Series E-2 Stock in connection with the
Subscription
Agreement (including shares issued in connection with any
subsequent conversion
of such Series E-2 Stock); (vi) as up to that number of shares
equal to 1% of
the aggregate number of shares (subject to equitable adjustment in
the event of
any stock dividend, stock split, combination, reorganization,
recapitalization
or similar event involving a change in the Common Stock) of
outstanding Common
Stock on an as-converted, fully-diluted basis (after giving effect
to the
issuance of the Series E-2 Stock pursuant to the Subscription
Agreement)
measured as of the date of the latest issuance of Series E-2 Stock
issued after
the date hereof, in each case, in accordance with the terms of the
Subscription
Agreement, to institutional lenders in connection with the
establishment or
maintenance by the Company of credit facilities, including
equipment lease
facilities, approved in each case by a majority of the Board of
Directors of the
Company; (vii) pursuant to a registered public offering, the
closing of which is
on or after the date hereof; (viii) as up to that number of shares
equal to 1%
of the aggregate number of shares (subject to equitable adjustment
in the event
of any stock dividend, stock split, combination,
reorganization,
recapitalization or similar event involving a change in the Common
Stock) of
outstanding Common Stock on an as-converted, fully-diluted basis
(after giving
effect to the issuance of the Series E-2 Stock pursuant to the
Subscription
Agreement) measured as of the date of the latest issuance of Series
E-2 Stock
issued after the date hereof, in each case, in accordance with the
terms of the
Subscription Agreement in connection with the sale of Common Stock
or
Convertible Securities of the Company to any licensor of technology
or patent
rights to the Company or to any collaborative partner or licensee
with respect
to the development or commercialization of products; or (ix) as up
to that
number of shares equal to 4% of the aggregate number of shares
(subject to
equitable adjustment in the event of any stock dividend, stock
split,
combination, reorganization, recapitalization or similar event
involving a
change in the Common Stock) of outstanding Common Stock on an
as-converted,
fully-diluted basis (after giving effect to the issuance of the
Series E-2 Stock
pursuant to the Subscription Agreement) measured as of the date of
the latest
issuance of Series E-2 Stock issued after the date hereof, in each
case, in
accordance with the terms of the Subscription Agreement in
connection with the
acquisition by the Company of another business entity by
merger,
6
<PAGE>
purchase of all or substantially all of its assets or acquisition
of all or
substantially all of the equity interest of such business
entity.
3.
RESTRICTIONS ON TRANSFER
3.1. NON-COMPLYING TRANSFERS PROHIBITED. No Founder may sell,
assign, transfer,
exchange, gift, devise, pledge, hypothecate, encumber or otherwise
alienate or
dispose of any Shares owned by such Founder, or any right or
interest therein,
whether voluntarily or involuntarily, by operation of law or
otherwise, except
in accordance with this Agreement. Notwithstanding the foregoing, a
Founder may
transfer any or all of his Shares (i) to his spouse or children or
to a trust
established for the benefit of his spouse, children or himself, or
(ii) under
his will (each such transferee, a "Permitted Transferee"); provided
that such
Shares shall remain subject to this Agreement and such permitted
transferee
shall, as a condition to such transfer, deliver to the Company a
written
instrument confirming that such transferee shall be bound by all of
the terms
and conditions of this Agreement. The restrictions on the transfer
of shares by
the Founders are in addition to, and not in lieu of, any
restrictions on such
Shares contained in each of the Stock Restriction Agreements
between the
Founders and the Company dated August 19, 1998.
3.2. RIGHTS OF FIRST
REFUSAL ON VOLUNTARY TRANSFERS.
3.2.1.
RIGHT OF FIRST REFUSAL OF THE COMPANY. Except in cases
explicitly
permitted
by Section 3.1, any Founder who intends to sell, assign,
transfer
or otherwise voluntarily alienate or dispose of any Shares (the
"Selling
Stockholder") shall, prior to any such transfer, give written
notice
(the "Selling Stockholder's Notice") of such intention to the
Company
and to each Qualified Stockholder. The Selling Stockholder's
Notice
shall include the name of the proposed transferee, the proposed
purchase
price per Share, the terms of payment of such purchase price
and
all other
matters relating to such sale and shall be accompanied by a
copy
of a
binding written agreement of the proposed transferee to purchase
such
Shares
from the Selling Stockholder. The Selling Stockholder's Notice
shall
constitute a binding offer by the Selling Stockholder to sell to
the
Company
all or any part of such number of Shares (the "Offered Shares")
then owned
by the Selling Stockholder as are proposed to be sold in the
Selling
Stockholder's Notice at the monetary price per Share designated
in
the
Selling Stockholder's Notice, payable as provided in Section
3.2.3
hereof.
Not later than thirty (30) days after receipt of the Selling
Stockholder's Notice, the Company shall deliver written notice
(the
"Company
Notice") to the Selling Stockholder stating whether the Company
has
accepted the offer stated in the Selling Stockholder's Notice
(in
whole or in
part). The closing of any purchase of the Offered Shares by
the
Company shall take place on the later of (i) fifteen (15) days
after
the end of
the thirty (30) day period set forth above and (ii) the date on
which the
Buying Stockholders (as hereinafter defined in Section 3.2.2)
consummate
any purchase of Offered Shares pursuant to Section 3.2.2 below.
7
<PAGE>
3.2.2.
RIGHT OF FIRST REFUSAL OF THE STOCKHOLDERS. If the Company does
not
accept the
offer to purchase all of the Offered Shares within the thirty
(30) day
period provided in Section 3.2.1, no later than the end of such
thirty
(30) day period the Company shall give notice (the "Second
Company
Notice") of that
fact to each Qualified Stockholder, and each Qualified
Stockholder shall have the right to purchase all or any part of
its
Proportionate Percentage (as defined below) of the Offered Shares
not
purchased
by the Company (the "Remaining Shares"), at the monetary price
per Share
designated in the Selling Stockholder's Notice, payable as
provided
in Section 3.2.3. Not later than fifteen (15) days after
delivery
of the
Second Company Notice, each Qualified Stockholder shall deliver
to
the
Company, the other Qualified Stockholders and the Selling
Stockholder
a written
notice stating whether such Qualified Stockholder has accepted
the offer
stated in the Selling Stockholder's Notice with respect to its
Proportionate Percentage of the Remaining Shares. Promptly
following the
expiration
of such fifteen (15) day period, the Company shall notify each
Qualified
Stockholder that has exercised its rights under this Section
3.2.2
(each a "Buying Stockholder") of the number of Remaining Shares
(if
any) that
other Qualified Stockholders have not elected to purchase. If
one or
more of the Qualified Stockholders elects not to purchase all
of
the
Remaining Shares which it is entitled to purchase pursuant to
this
Section
3.2.2, the Buying Stockholders, by written notice to the
Company
and the
Selling Stockholder within five (5) days after the delivery of
the
Company's
notice pursuant to the proceeding sentence, may elect to
purchase
all or a part of such unpurchased Remaining Shares without the
consent of
any non-purchasing Qualified Stockholders, pro rata between or
among them
or in such other manner as they may agree. The closing of any
purchase
of the Remaining Shares by the Buying Stockholders shall take
place no
later than fifteen (15) days after the end of the fifteen (15)
day period
set forth above. As used in this Section 3.2.2, "Proportionate
Percentage" shall mean with respect to each Qualified Stockholder
a
fraction,
the numerator of which is the number of Shares owned by such
Qualified
Stockholder (calculated on a fully diluted basis), and the
denominator of which is the total number of Shares owned by all
the
Qualified
Stockholders (calculated on a fully-diluted basis).
3.2.3.
CLOSING. The place for the closing of any purchase and sale
described
in Section 3.2.1 or Section 3.2.2 shall be the principal office
of the
Company or at such other place as the parties shall agree. At
the
closing,
the Selling Stockholder shall accept payment on the terms
offered
by the
proposed transferee named in the Selling Stockholder's Notice,
provided,
however, that the Company and the Buying Stockholders shall not
be
required to meet any non-monetary terms of the proposed
transfer,
including,
without limitation, delivery of other securities in exchange
for the
Shares proposed to be sold. At the closing, the Selling
Stockholder shall deliver to the Company or the Buying
Stockholders, as
the case
may be, in exchange for Shares purchased and sold at the
closing,
certificates for the number of Shares stated in the Selling
Stockholder's
Notice,
accompanied by duly executed instruments of transfer.
8
<PAGE>
3.2.4.
TRANSFERS TO THIRD PARTIES. If the Company and the Buying
Stockholders in aggregate fail to accept the offer stated in the
Selling
Stockholder's Notice with respect to all of the Offered Shares,
they shall
not have
the right to purchase any Offered Shares, and the Selling
Stockholder shall, subject to Section 3.3 herein, be free to sell
all, but
not less
than all, of the Offered Shares to the designated transferee at
a
price and
on terms no less favorable to the Selling Stockholder than
described
in the Selling Stockholder's Notice, provided, however, that
such sale
is consummated within ninety (90) days after the giving of the
Selling
Stockholder's Notice pursuant to Section 3.2.1. As a condition
precedent
to the effectiveness of a transfer pursuant to this Section
3.2.4, the
proposed transferee(s) shall agree in writing prior to such
transfer
to become a party to this Agreement and shall thereafter be
permitted
to transfer Shares only in accordance with this Agreement.
3.3. PARTICIPATION IN
SALES.
3.3.1.
TAKE-ALONG RIGHT. In the event that a Founder (the "Offeree")
receives a
bona fide offer from a third party or parties other than the
Company or
any other Stockholder (the "Third Party Buyer") to purchase any
of the
Shares owned by the Offeree (the "Take-Along Shares"), for a
specified
price payable in cash or otherwise and on specified terms and
conditions
(the "Offer"), and the Offeree proposes to sell or otherwise
transfer
the Take-Along Shares to the Third Party Buyer pursuant to the
Offer,
each Qualified Stockholder shall have the right to sell to the
Third
Party Buyer, at the same price per Share and on the same terms
and
conditions
as stated in the Offer, up to the number of Shares equal to the
Take-Along
Shares multiplied by a fraction, the numerator of which is the
aggregate
number of Shares owned by such Qualified Stockholder
(calculated
on a fully
diluted, as converted to Common Stock basis) and the
denominator shall be the aggregate number of Shares held by all
stockholders (calculated on a fully-diluted, as converted to Common
Stock
basis),
provided, however, that if the prospective third-party
purchaser
objects to
the delivery of any series of Preferred Stock in lieu of Common
Stock,
such selling Qualified Stockholder shall convert such Preferred
Stock into
Common Stock and deliver Common Stock as provided in this
Section
3.3.1. The Company agrees to make any such conversion
concurrent
with the
actual transfer of such shares to the purchaser and contingent
on
such
transfer; and provided further, that such rights of the
Qualified
Stockholders granted pursuant to this 3.3.1 shall not apply to
the
transfer
or transfers by a Founder of up to 100,000 Shares in the
aggregate
(subject to appropriate adjustment for stock splits, stock
dividends,
combinations and similar recapitalization events) (a "Permitted
Transfer"), provided that, such Shares transferred pursuant to a
Permitted
Transfer
shall remain subject to this Agreement and such permitted
transferee
shall, as a condition to such transfer, deliver to the Company
a written
instrument confirming that such transferee shall be bound by
all
of the
terms and conditions of this Agreement.
3.3.2.
NOTICES OF OFFER AND INTENT TO PARTICIPATE. If a Qualified
Stockholder wishes to participate in any sale pursuant to Section
3.3.1 it
shall
notify the
9
<PAGE>
Offeree in
writing of such intention and the number of Shares it wishes to
sell
pursuant to this Section 3.3 not later than fifteen (15) days
after
delivery
of the Second Company Notice (as described in Section 3.2.2
above). If
the Offeree does not receive such notice from a Qualified
Stockholder within such fifteen (15) day period, the Offeree shall
be free
to
consummate the proposed transaction without any obligation to
include
such
Qualified Stockholder's Shares in such transaction. The
non-exercise
or partial
exercise of the rights of any Qualified Stockholder hereunder
to
participate in one or more sales of Shares made by a Founder shall
not
adversely
affect such Qualified Stockholder's right to participate in
subsequent
sales of Shares by a Founder.
3.3.3.
SALE OF TAKE-ALONG SHARES. The Offeree and each Qualified
Stockholder who has provided timely notice in accordance with
Section
3.3.2
above shall sell to the Third Party Buyer all, or at the option
of
the Third
Party Buyer, any part of the Shares proposed to be sold by them
at not
less than the price and upon other terms and conditions, if
any,
not more
favorable to the Third Party Buyer than those stated in the
Offer,
provided, however, that any purchase of less than all of such
Shares by
the Third Party Buyer shall be made from the Offeree and each
Qualified
Stockholder pro rata based upon the relative amount of the
Shares
that the Offeree and such Qualified Stockholder is entitled to
sell
pursuant
to Section 3.3.1. The stock certificate or certificates that
the
selling
Qualified Stockholder delivers to the Offeree pursuant to this
Section
3.3 shall be transferred to the prospective purchaser in
consummation of the sale of the Shares pursuant to the terms
and
conditions
specified in the transfer notice, and the Offeree shall
concurrently therewith remit to such selling Qualified Purchaser
that
portion of the sale
proceeds to which such selling Qualified Purchaser is
entitled
by reason of its participation in such sale. To the extent that
any
prospective purchaser or purchasers prohibits such assignment
or
otherwise
refuses to purchase shares or other securities from a selling
Qualified
Stockholder exercising its take along rights hereunder, the
Offeree
shall not sell to such prospective purchaser or purchasers any
Shares
unless and until, simultaneously with such sale, the Offeree
shall
purchase
such shares or other securities from such selling Qualified
Stockholder for the same consideration and on the same terms
and
conditions
as the proposed transfer described in the transfer notice.
3.3.4. PROHIBITED
TRANSFERS.
(a) In the event any Founder should sell any Shares in
contravention
of the
take-along rights of the Qualified Stockholders under Section 3
(a
"Prohibited Transfer"), the Qualified Stockholders, in addition to
such
other
remedies as may be available at law, in equity or hereunder,
shall
have the
put option provided below, and such Founder
shall be
bound by the applicable provisions of such option.
(b) In the event of a Prohibited Transfer, each Qualified
Stockholder shall have the right to sell to such Founder the type
and
number of
the Shares equal to the number of shares each Qualified
Stockholder would have been
10
<PAGE>
entitled
to transfer to the third-party transferee(s) under Section 3.3
hereof had
the Prohibited Transfer been effected pursuant to and in
compliance
with the terms hereof. Such sale shall be made on the following
terms and
conditions:
(i) The price per share at which the shares are to be sold to
such Founder shall be equal to the price per share paid by the
third-party transferee(s) to such Founder in the Prohibited
Transfer. Such Founder shall also reimburse each Qualified
Stockholder for any and all fees and expense, including legal
fees
and expenses, incurred pursuant to the exercise or the
attempted
exercise of the Qualified Stockholder's rights under Section
3.3.4.
(ii) Within 45 days after the later of the dates on which the
Qualified Stockholder (A) received notice of the Prohibited
Transfer
or (B) otherwise became aware of the Prohibited Transfer, each
Qualified Stockholder shall, if exercising the option created
hereby, deliver to such Founder the certificate or certificates
representing shares to be sold, each certificate to be properly
endorsed for
transfer.
(iii) Such Founder shall, upon receipt of the certificate or
certificates for the shares to be sold by a Qualified
Stockholder,
pursuant to this Section 3.3.4, pay the purchase price therefor
and
the amount of reimbursable fees and expenses, as specified in
Section 3.3.4(b)(i), in cash or by other means acceptable to
such
Qualified Stockholder.
(iv) Notwithstanding the foregoing, any attempt by a Founder
to transfer the Shares in violation of this Agreement shall be
null
and void ab initio and the Company agrees it will not effect such
a
transfer nor will it treat any alleged transferee(s) as the owner
of
such shares without the written consent of a majority in interest
of
the Qualified Stockholders.
(c) The Qualified Stockholders, severally but not jointly, will
indemnify
the Company against all liabilities incurred by the Company
relating
to tax obligations owed by the Company pursuant to the exercise
by such
Qualified Stockholders of the option set forth in this Section
3.3.4.
3.4. COMPANY RECORDS. The Company shall not transfer on its books
any of the
shares of Common Stock held by any Stockholder or Permitted
Transferee without
first ascertaining compliance with all of the applicable provisions
of this
Agreement with respect to such transfer. Each Founder agrees that,
in order to
ensure compliance with the restrictions referred to herein, the
Company may
issue appropriate "stop-transfer" instructions to its transfer
agent, if any,
and that, if the Company transfers its own securities, it may make
appropriate
notations to the same effect in its own records. The Company shall
not be
required (i) to transfer on its books any Shares that have been
sold or
otherwise transferred in violation of any of the provisions of this
Section 3.3,
or (ii) to treat as owner of such Shares or to accord the right to
vote or pay
dividends to any purchaser or other transferee to whom such Shares
shall have
been transferred.
11
<PAGE>
3.5. LEGEND-REQUIREMENT. All certificates evidencing Shares subject
to Section
3.3 herein shall, during the term of this Agreement, bear such
restrictive
legends as the Company and the Company's counsel deem necessary or
advisable
under applicable law or pursuant to this Agreement, including
without limitation
the following (or a substantially similar legend):
"THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO A RIGHT OF
CO-SALE
BY CERTAIN
SHAREHOLDERS OF THE COMPANY, PURSUANT TO AN AGREEMENT RELATING
TO SUCH
SECURITIES, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT
IN
COMPLIANCE
WITH THE TERMS OF SUCH AGREEMENT."
4.
TRANSFER OF REGISTRABLE SECURITIES; REGISTRATION
4.1. RESTRICTIVE LEGEND. Each certificate representing shares of
Preferred Stock
or Registrable Securities shall, except as otherwise provided in
this Section
4.1 or in Section 4.2, be stamped or otherwise imprinted with a
legend
substantially in the following form (in addition to any legend
required under
applicable state securities laws):
"The securities represented by this certificate have not been
registered under the Securities Act of 1933, as amended, or any
other securities laws. These securities have been acquired for
investment and not with a view to distribution or resale. Such
securities may not be offered for sale, sold, delivered after
sale,
transferred, pledged or hypothecated in the absence of an
effective
registration statement covering such securities under the
Securities
Act of 1933 and any other applicable securities laws, unless
the
holder shall have obtained an opinion of counsel reasonably
satisfactory to the corporation that such registration is not
required."
Upon
request of a Holder of such a certificate, the Company shall
remove
the foregoing legend (as well as the legend set forth in Section
4.2 of the
Subscription Agreement) from the certificate or issue to such
Holder a new
certificate therefor free of any transfer legend, if there is an
effective
registration statement covering the securities represented by such
certificate
or, with such request, the Company shall have received either the
opinion
referred to in Section 4.2(i) or the "no-action" letter referred to
in Section
4.2(ii).
4.2. NOTICE OF PROPOSED TRANSFER. Prior to any proposed sale,
pledge,
hypothecation or other transfer of any shares of Preferred Stock or
Registrable
Securities (other than under the circumstances described in Section
4.3, 4.4 or
4.5), the Holder thereof shall give written notice to the Company
of its
intention to effect such sale, pledge, hypothecation or other
transfer. Each
such notice shall describe the manner of the proposed sale,
pledge,
hypothecation or other transfer and, if requested by the
Company
12
<PAGE>
shall be accompanied by either (i) an opinion of counsel reasonably
satisfactory
to the Company stating that that the proposed sale, pledge,
hypothecation or
other transfer may be effected without registration under the
Securities Act or
(ii) a "no action" letter from the Commission to the effect that
the
distribution of such securities without registration will not
result in a
recommendation by the staff of the Commission that action be taken
with respect
thereto, whereupon the Holder of such stock shall be entitled to
transfer such
stock in accordance with the terms of its notice; provided,
however, that no
such opinion of counsel shall be required for (x) a distribution to
one or more
partners of the transferor (in the case of a transferor that is a
partnership),
stockholders (in the case of a transferor that is a corporation) or
members (in
the case of a transferor that is a limited liability company) in
each case in
respect of the beneficial interest of such partner, stockholder or
member or (y)
Affiliates, except in the case of clause (y), as the Company shall
otherwise
reasonably request. Each certificate for Preferred Stock or
Registrable
Securities transferred as above provided shall bear the appropriate
restrictive
legend set forth in Section 4.1, except that such certificate shall
not bear
such legend if (i) such transfer is in accordance with the
provisions of Rule
144 (or any other rule permitting public sale without registration
under the
Securities Act) or (ii) the opinion of counsel or "no-action"
letter referred to
above is to the further effect that the transferee and any
subsequent transferee
(other than an affiliate of the Company) would be entitled to
transfer such
securities in a public sale without registration under the
Securities Act or
that such legend is not required to establish compliance with any
provisions of
the Securities Act. Notwithstanding any other provision hereof, the
restrictions
provided for in this Section 4.2 shall not apply to securities
which are not
required to bear the legend prescribed by Section 4.1 in accordance
with the
provisions of that Section. If the Company does not accept an
opinion of counsel
required hereby signed by the original Holder's counsel, the
Company will pay
the reasonable fees and disbursements of other counsel in
connection with all
opinions rendered by them pursuant to this Section 4.2.
4.3. REGISTRATION ON
FORM S-1.
(a) If at any time, Holders of more than 20% of the outstanding
shares of
Registrable Securities request that the Company file a
registration statement for at least 20% of the shares of the
outstanding
Registrable Securities, (such Holders, the "Initiating
Holders")
anticipated aggregate proceeds of which, net of underwriting
discounts and
commissions, would exceed $10,000,000, the Company shall:
(i) within ten days of the receipt by the Company of such
notice, give written notice of the proposed registration,
qualification or compliance to all other Holders; and
(ii)